Scientific considerations for complex drugs in light of established and emerging regulatory guidance.
Saved in:
| Title: | Scientific considerations for complex drugs in light of established and emerging regulatory guidance. |
|---|---|
| Authors: | Holloway C; ERA Consulting Group, Walsrode, Germany., Mueller-Berghaus J, Lima BS, Lee SL, Wyatt JS, Nicholas JM, Crommelin DJ |
| Source: | Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2012 Dec; Vol. 1276, pp. 26-36. Date of Electronic Publication: 2012 Nov 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: New York Academy of Sciences Country of Publication: United States NLM ID: 7506858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1749-6632 (Electronic) Linking ISSN: 00778923 NLM ISO Abbreviation: Ann N Y Acad Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1749-6632 |
|---|---|
| DOI: | 10.1111/j.1749-6632.2012.06811.x |
